Key messages
- Pharmacotherapy is an effective treatment for opioid dependence.
- The department has developed a policy for prescribers and pharmacists to help them make safe, effective and legal decisions about treating patients on pharmacotherapy.
Pharmacotherapy, or opioid replacement therapy (ORT) is an effective treatment for opioid dependence.
Pharmacotherapy can be used for several types of patients:
- those who have used heroin for a long time
- those experiencing problematic use of prescription opioids and over-the-counter codeine-containing analgesics.
Studies have shown that many people who stop using opioids will relapse and start using illicit opioids. Maintenance pharmacotherapies can prove valuable in assisting these people to successfully manage physical dependence, drug craving and compulsive drug use.
Methadone and buprenorphine have been used to treat opioid dependence, both in detoxification from opioids and maintenance treatment.
Revised Policy for maintenance pharmacotherapy for opioid dependence
Victoria's current Policy for maintenance pharmacotherapy for opioid dependence has been revised and is effective from 1 September 2016.
There is significant focus in the revised Policy on pharmacotherapy take-away doses, which can be fatal if diverted, shared or ingested incorrectly.
Pharmacotherapy providers are encouraged read the revised policy and understand that the tightened guidelines deliver stronger, clearer, safer and additional advice on the provision of pharmacotherapies throughout Victoria.
Medication assisted treatment of opioid dependence (MATOD)
For guidance on medication assisted treatment of opioid dependence, see the following resources on the Health services and general practice - coronavirus disease (COVID-19) page of the Department of Health and Human Services website.
- Pharmacotherapy services: information for prescribers and dispensers (PDF)
- Checklist for assessing appropriateness of take-away doses to support continuity of pharmacotherapy during the COVID-19 pandemic (PDF)
- Guidance for supplying methadone and buprenorphine (+/- naloxone) dose(s) to a third party in the context of the COVID-19 pandemic (PDF)
Reviewed 22 August 2022
Health.vic
-
- Hospitals & health services
- Health Service Partnerships
- Public hospitals in Victoria
-
- Quality, safety and service improvement
- Planned surgery recovery and reform program
- My Health Record
- Collecting patient-reported outcome measures in Victoria
- Public hospital accreditation in Victoria
- Improvement and Innovation Program
- Credentialing for senior medical staff in Victoria
- Clinical risk management
- Preventing infections in health services
- Healthy choices
- Victorian Perinatal Data Collection
-
- Rural health
- Improving Access to Primary Care in Rural and Remote Areas Initiative
- Rural x-ray services
- Rural health regions and locations
- Rural and regional medical director role
- Victorian Patient Transport Assistance Scheme
- Rural and isolated practice registered nurses
- Urgent care in regional and rural Victoria
-
- Private health service establishments
- Private hospitals
- Day procedure centres
- Mobile health services
- Fees for private health service establishments in Victoria
- Design resources for private health service establishments
- Professional standards in private health service establishments
- Legislation updates for private health service establishments
- Complaints about private health service establishments
- Cosmetic procedures
- Guideline for providers of liposuction
- Private hospital funding agreement
-
- Primary & community health
- Local Public Health Units
- Integrated care
-
- Maternal and Child Health Service
- Maternal and Child Health Service Framework
- Maternal and Child Health Service resources
- Child Development Information System
- Early parenting centres
- Maternal Child and Health Reporting, Funding and Data
- Baby bundle
- Sleep and settling
- Maternal and Child Health Workforce professional development
- Aboriginal Maternal and Child Health
- Public Dental and Community Health Program funding model review
-
- Public health
-
- Cemeteries and crematoria
- Cemetery trust member appointments
- Cemetery search
- Cemeteries and crematoria complaints
- Cremations
- Exhumations
- Governance and finance
- Cemetery grants
- Interments and memorials
- Land and development
- Legislation governing Victorian cemeteries and crematoria
- Cemeteries and crematoria publications
- Repatriations
- Rights of interment
-
- Medicines and Poisons Regulation
- Patient Schedule 8 treatment permits
- Schedule 9 permits for clinical trials
- Documents and forms to print or download
- Legislation and Approvals
- Frequently Asked Questions - Medicines and Poisons Regulation
- Health practitioners
- Licences and permits to possess (& possibly supply) scheduled substances
- Medicinal cannabis
- Pharmacotherapy (opioid replacement therapy)
- Recent updates
- SafeScript
-
- Environmental health
- Improving childhood asthma management in Melbourne's inner west
- Climate and weather, and public health
- Environmental health in the community
- Environmental health in the home
- Environmental health professionals
- Face masks for environmental hazards
- Human health risk assessments
- Lead and human health
- Per- and poly-fluoroalkyl substances (PFAS)
- Pesticide use and pest control
-
- Immunisation
- Vaccination program for adults
- Seasonal influenza vaccine
- Immunisation provider information
- Immunisation resources order form
- Vaccine error management
- Adverse events following immunisation reporting
- Cold chain management
- Immunisation schedule and vaccine eligibility criteria
- Immunisers in Victoria
- Immunity for community
- Immunisation for special-risk groups
- Vaccination for adolescents
- Vaccination of infants and children
- Ordering vaccine
- Victorian coverage rates for Victoria
- Yellow fever vaccination centres
-
- Infectious diseases
- Disease information and advice
- Infection control guidelines
- Infectious diseases surveillance in Victoria
- Notification procedures for infectious diseases
- Notifiable infectious diseases, conditions and micro-organisms
- Protecting patient privacy in Victoria
- Public Health and Wellbeing Act 2008
-
- Mental health
- Mental Health and Wellbeing Act 2022
-
- About Victoria's mental health services
- Area-based services
- Statewide and specialist mental health services
- Mental Health Community Support Services
- Support and intervention services
- Language services - when to use them
- Access to mental health services across areas
- Transport for people in mental health services
- Order mental health publications
-
- Alcohol & drugs
-
- Alcohol and other drug treatment services
- Overview of Victoria's alcohol and drug treatment system
- Pathways into alcohol and other drugs treatment
- Prevention and harm reduction
- Medically supervised injecting room
- Community-based AOD treatment services in Victoria
- Residential treatment services
- Drug rehabilitation plan
- Hospital-based services
- Forensic services
- Pharmacotherapy treatment
- Services for Aboriginal people
- Services for young people
- Statewide and specialist services
- Compulsory treatment
- Family and peer support
-
- Alcohol and other drug service standards and guidelines
- Alcohol and other drug client charter and resources
- Alcohol and other drug treatment principles
- Service quality and accreditation
- Alcohol and other drug program guidelines
- Maintenance pharmacotherapy
- Drink and Drug Driving Behaviour Change Program
- Alcohol and Other Drug Residential Rehabilitation Facility Design Guidelines
- Specialist Family Violence Advisor capacity building program in mental health and alcohol and other drug services - Victoria
-
- Ageing & aged care
- My Aged Care assessment services
-
- Dementia-friendly environments
- Designing for people with dementia
- Maintaining personal identity
- Personal enjoyment
- Interior design
- Dining areas, kitchens and eating
- Bedrooms and privacy
- Bathrooms
- Gardens and outdoor spaces
- Assistive technology
- Staff education and support
- Strategies, checklists and tools
- References
-
- About us
- Our operational plan
- Our ministers
-
- Health workforce
- Medical workforce in Victoria
-
- Nursing and midwifery
-
- Free nursing and midwifery study
- Undergraduate nursing and midwifery scholarships
- Enrolled nurse to registered nurse transition scholarships
- Re-entry pathway scholarships for nurses and midwives
- Refresher pathway for nurses and midwives
- Postgraduate scholarships for nurses and midwives
- Support for new nurse practitioners
- Additional funding for nursing and midwifery positions
- Undergraduate student employment
- Nursing and Midwifery Workforce Development Fund
- Becoming a nurse or midwife
- Furthering your nursing and midwifery career
- Midwives in Victoria
- Inter-professional Nurse Paramedic Graduate Program
- Returning to nursing or midwifery
- Safe Patient Care
- Aboriginal graduate and cadetship programs
- Allied health workforce
- Education and training
- Enterprise agreements
- Worker health and wellbeing
- Information sharing and MARAM
- Recognition and awards
- Our campaigns
Support services
- Drug and Alcohol Clinical Advisory Service (DACAS) Ph: 1800 812 804 (24 hours, 7 days)
- DirectLine Ph: 1800 888 236 (24 hours, 7 days)
- Pharmacotherapy advocacy, mediation and support (PAMS) service Ph: 1800 443 844
More information
Contact us
Department of Health
Victorian Opioid Pharmacotherapy Program Mental Health and Wellbeing Division